Breaking News Instant updates and real-time market news.

AMRN

Amarin

$21.07

-0.67 (-3.08%)

16:08
07/17/19
07/17
16:08
07/17/19
16:08

Amarin drops 8% to $19.37 after announcing $400M secondary offering

  • 28

    Sep

AMRN Amarin
$21.07

-0.67 (-3.08%)

07/03/19
HCWC
07/03/19
NO CHANGE
Target $51
HCWC
Buy
Amarin guidance highlights continued Vascepa traction, says H.C. Wainwright
Amarin's updated revenue guidance yesterday highlights the continued U.S. prescription traction of Vascepa, H.C. Wainwright analyst Andrew Fein tells investors in a research note. The analyst finds the guidance updates in line with his 100 physician survey, which suggests Amarin "remains in the early stages of Vascepa launch with significant upside ahead coinciding with growing physician awareness." Fein reiterates a Buy rating on the shares with a $51 price target.
07/03/19
ROTH
07/03/19
NO CHANGE
Target $31
ROTH
Buy
Amarin 'just getting started' as Vascepa sales sets new high, says Roth Capital
Roth Capital analyst Yasmeen Rahimi notes that Amarin provided record revenue for the first half of 2019 for Vascepa, guided $380M-420M for 2019 and unveiled its plans to increase its U.S. sales team to about 800 in October 2019. The analyst believes the company's power move is just the beginning of transformation into a money maker, while noting that there is still no word on AdCom as PDUFA approaches. Rahimi reiterates a Buy rating and $31 price target on the shares.
07/09/19
AGIS
07/09/19
INITIATION
Target $3
AGIS
Buy
Aegis starts 'promising Omega-3 story' Acasti with Buy rating, $3 price target
As previously reported, Aegis analyst Nathan Weinstein initiated Acasti Pharma (ACST) with a Buy rating and $3 price target, telling investors that the company's Omega-3 therapeutic for the treatment of very high triglycerides, called CaPre, has demonstrated "interesting efficacy" in phase 2 study. Several companies have entered or could be close to entering the prescription Omega-3 space, including Amarin (AMRN), but Weinstein points to precedent cases of third and later entrants achieving market success in various therapeutic categories.
07/09/19
JEFF
07/09/19
NO CHANGE
JEFF
Buy
Amarin weakness may be due to hiring worries, Citizen's Petition, says Jefferies
Jefferies analyst Michael Yee noted that Amarin shares have been weak today and he said that investors he has spoke with have discussed the company's plans to double its salesforce near-term, which would increase operating expenses and the use of cash. Yee said he is also aware that there was a Citizen's Petition filed today by a group seeking to invalidate the company's '146 manufacturing patent, challenging the concept of producing pure EPA from crude fish oil. However, he said that a Citizen Petitions to invalidate a patent would seem challenging, as he thinks the more appropriate medium would be a formal court process or an IPR challenge. The petition "sounds noisy," added Yee, who has a Buy rating on Amarin shares.

TODAY'S FREE FLY STORIES

WHR

Whirlpool

$159.20

0.77 (0.49%)

13:37
10/15/19
10/15
13:37
10/15/19
13:37
Periodicals
AHAM reports U.S. appliance shipments down 4.5% in September, Bloomberg says »

The Association of Home…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

BAC

Bank of America

$29.95

0.8 (2.74%)

13:33
10/15/19
10/15
13:33
10/15/19
13:33
Recommendations
Bank of America analyst commentary  »

Wells Fargo positive on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

BRK.A

Berkshire Hathaway

$314,150.06

2587.06 (0.83%)

, BRK.B

Berkshire Hathaway

$209.40

1.55 (0.75%)

13:33
10/15/19
10/15
13:33
10/15/19
13:33
Periodicals
Buffett seeks Fed permission to boost Bank of America stake, Bloomberg reports »

Warren Buffett's…

BRK.A

Berkshire Hathaway

$314,150.06

2587.06 (0.83%)

BRK.B

Berkshire Hathaway

$209.40

1.55 (0.75%)

BAC

Bank of America

$29.95

0.8 (2.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 12

    Nov

13:25
10/15/19
10/15
13:25
10/15/19
13:25
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

ZM

Zoom Video

$69.34

-1.49 (-2.10%)

13:25
10/15/19
10/15
13:25
10/15/19
13:25
Conference/Events
Zoom Video to host analyst meeting »

Analyst meeting to be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 16

    Dec

GM

General Motors

$36.32

0.81 (2.28%)

13:23
10/15/19
10/15
13:23
10/15/19
13:23
Periodicals
GM, UAW said to have agreement on temp worker arrangement, Bloomberg reports »

GM has agreed to make…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

LYFT

Lyft

$40.61

0.84 (2.11%)

13:21
10/15/19
10/15
13:21
10/15/19
13:21
Rumors
Rumor moving shares of Lyft »

Rumor: Lyft moves up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

  • 07

    Nov

  • 19

    Nov

USFD

US Foods

$39.29

-1.28 (-3.16%)

13:19
10/15/19
10/15
13:19
10/15/19
13:19
Recommendations
US Foods analyst commentary  »

US Foods chief supply…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

  • 12

    Nov

COST

Costco

$298.24

0.69 (0.23%)

13:19
10/15/19
10/15
13:19
10/15/19
13:19
Downgrade
Costco rating change  »

Costco downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/15/19
10/15
13:17
10/15/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FOX

Fox Corp.

$31.37

0.33 (1.06%)

, FOXA

Fox Corp.

$31.62

0.21 (0.67%)

13:16
10/15/19
10/15
13:16
10/15/19
13:16
Periodicals
Shari Redstone considers plan to launch Fox News rival, THR says »

As the merger between…

FOX

Fox Corp.

$31.37

0.33 (1.06%)

FOXA

Fox Corp.

$31.62

0.21 (0.67%)

CBS

CBS

$38.17

0.24 (0.63%)

CBS.A

$41.77

(0.00%)

VIA

Viacom

$25.28

0.015 (0.06%)

VIAB

Viacom

$22.87

0.145 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 06

    Nov

  • 06

    Nov

  • 12

    Nov

  • 12

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/15/19
10/15
13:16
10/15/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WE

We Company

$0.00

(0.00%)

13:12
10/15/19
10/15
13:12
10/15/19
13:12
Periodicals
Breaking Periodicals news story on We Company »

WeWork loses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RDS.A

Royal Dutch Shell

$57.92

0.08 (0.14%)

, RDS.B

Royal Dutch Shell

$58.44

0.14 (0.24%)

13:06
10/15/19
10/15
13:06
10/15/19
13:06
Periodicals
Shell CEO still sees big opportunties for investors in oil and gas, Reuters says »

Royal Dutch Shell CEO Ben…

RDS.A

Royal Dutch Shell

$57.92

0.08 (0.14%)

RDS.B

Royal Dutch Shell

$58.44

0.14 (0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VKTX

Viking Therapeutics

$6.56

0.17 (2.66%)

13:05
10/15/19
10/15
13:05
10/15/19
13:05
Options
Viking Therapeutics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CNPOF

Canopy Rivers

$0.00

(0.00%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Hot Stocks
Canopy Rivers portfolio company receives Health Canada license amendment »

Canopy Rivers announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CS

Credit Suisse

$12.26

0.28 (2.34%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Periodicals
Credit Suisse eyes adding more advisers to billionaire clients, Bloomberg says »

Credit Suisse is seeking…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CHGG

Chegg

$32.76

0.12 (0.37%)

13:02
10/15/19
10/15
13:02
10/15/19
13:02
Hot Stocks
Law firm initiates investigation into data breach at Chegg »

Federman & Sherwood,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Nov

  • 13

    Nov

CRWD

Crowdstrike

$55.38

0.87 (1.60%)

13:00
10/15/19
10/15
13:00
10/15/19
13:00
Recommendations
Crowdstrike analyst commentary  »

Crowdstrike should be…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Dec

13:00
10/15/19
10/15
13:00
10/15/19
13:00
General news
Treasury Action: yields continue to rise »

Treasury Action: yields…

FB

Facebook

$189.25

5.96 (3.25%)

, V

Visa

$178.66

1.31 (0.74%)

12:58
10/15/19
10/15
12:58
10/15/19
12:58
Periodicals
Facebook advances Libra amid backer mutiny, Business Insider says »

Facebook (FB) took…

FB

Facebook

$189.25

5.96 (3.25%)

V

Visa

$178.66

1.31 (0.74%)

MA

MasterCard

$278.77

2.29 (0.83%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

12:55
10/15/19
10/15
12:55
10/15/19
12:55
Conference/Events
Morgan Stanley analysts to hold an analyst/industry conference call »

Executive Director of…

APHA

Aphria

$5.40

1.07 (24.71%)

12:51
10/15/19
10/15
12:51
10/15/19
12:51
Recommendations
Aphria analyst commentary  »

Seaport Global says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Oct

  • 12

    Nov

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

, GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

12:44
10/15/19
10/15
12:44
10/15/19
12:44
Hot Stocks
Google Stadia launches on November 19th »

In a tweet, the Google…

GOOG

Alphabet

$1,240.28

22.05 (1.81%)

GOOGL

Alphabet Class A

$1,240.59

22.98 (1.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

, GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

12:40
10/15/19
10/15
12:40
10/15/19
12:40
Hot Stocks
Google announces Nest Wifi system »

Alphabet's Google…

GOOG

Alphabet

$1,240.62

22.39 (1.84%)

GOOGL

Alphabet Class A

$1,241.32

23.71 (1.95%)

TGT

Target

$111.99

0.85 (0.76%)

BBY

Best Buy

$68.65

-0.055 (-0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.